$EFX

EQUIFAX INC

CIK:0000033185|SEC Filings

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Operating revenue	$ 1,700.1	$ 1,537.0	$ 3,349.0	$ 2,979.0
Operating expenses:
Cost of services (exclusive of depreciation and amortization below)	773.7	664.6	1,540.7	1,321.2
Selling, general and administrative expenses	422.5	384.2	833.6	759.1
Depreciation and amortization	189.7	177.4	372.8	352.0
Total operating expenses	1,385.9	1,226.2	2,747.1	2,432.3
Operating income	314.2	310.8	601.9	546.7
Interest expense	(59.8)	(53.1)	(115.5)	(106.0)
Other income, net	2.5	3.6	6.3	6.0
Consolidated income before income taxes	256.9	261.3	492.7	446.7
Provision for income taxes	(71.8)	(68.7)	(134.3)	(120.3)
Consolidated net income	185.1	192.6	358.4	326.4
Less: Net income attributable to noncontrolling interests including redeemable noncontrolling interests	(1.2)	(1.3)	(3.0)	(2.1)
Net income attributable to Equifax	$ 183.9	$ 191.3	$ 355.4	$ 324.3
Basic earnings per common share:
Net income attributable to Equifax (in dollars per share)	$ 1.55	$ 1.54	$ 2.98	$ 2.61
Weighted-average shares used in computing basic earnings per share (in shares)	118.4	124.0	119.2	124.1
Diluted earnings per common share:
Net income attributable to Equifax (in dollars per share)	$ 1.54	$ 1.53	$ 2.96	$ 2.59
Weighted-average shares used in computing diluted earnings per share (in shares)	119.2	125.0	119.9	125.1
Dividends per common share (in dollars per share)	$ 0.56	$ 0.50	$ 1.12	$ 0.89

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating activities:
Consolidated net income	$ 358.4	$ 326.4
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization	376.2	355.7
Stock-based compensation expense	60.5	46.6
Deferred income taxes	38.0	(7.3)
Gain on sale of equity investment	0.0	(0.8)
Changes in assets and liabilities, excluding effects of acquisitions:
Accounts receivable, net	(91.2)	(69.0)
Other assets, current and long-term	(119.3)	(24.8)
Current and long term liabilities, excluding debt	(40.9)	(41.8)
Cash provided by operating activities	581.7	585.0
Investing activities:
Capital expenditures	(255.4)	(229.4)
Cash received from divestitures	0.0	0.8
Cash used in investing activities	(255.4)	(228.6)
Financing activities:
Net short-term borrowings (payments)	647.8	(115.9)
Payments on long-term debt	(276.4)	0.0
Treasury stock purchases	(560.0)	(127.4)
Payment of share repurchase excise tax	(8.3)	0.0
Dividends paid to Equifax shareholders	(133.5)	(110.5)
Distributions paid to noncontrolling interests	(5.6)	(4.2)
Proceeds from exercise of stock options and employee stock purchase plan	16.8	24.4
Payment of taxes related to settlement of equity awards	(15.4)	(13.2)
Debt issuance costs	(0.3)	0.0
Cash used in financing activities	(334.9)	(346.8)
Effect of foreign currency exchange rates on cash and cash equivalents	(2.1)	9.5
(Decrease) increase in cash and cash equivalents	(10.7)	19.1
Cash and cash equivalents, beginning of period	180.8	169.9
Cash and cash equivalents, end of period	$ 170.1	$ 189.0

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 170.1	$ 180.8
Trade accounts receivable, net of allowance for doubtful accounts of $20.5 and $20.2 at June 30, 2026 and December 31, 2025, respectively	1,104.0	1,012.7
Prepaid expenses	166.5	144.2
Other current assets	140.7	74.5
Total current assets	1,581.3	1,412.2
Property and equipment:
Total property and equipment	3,414.1	3,637.1
Less accumulated depreciation and amortization	(1,484.9)	(1,704.7)
Total property and equipment, net	1,929.2	1,932.4
Goodwill	6,792.8	6,745.7
Indefinite-lived intangible assets	94.7	94.8
Purchased intangible assets, net	1,224.2	1,331.3
Other assets, net	359.6	347.8
Total assets	11,981.8	11,864.2
Current liabilities:
Short-term debt and current maturities of long-term debt	1,410.3	1,038.0
Accounts payable	126.6	206.4
Accrued expenses	331.0	276.3
Accrued salaries and bonuses	165.9	286.1
Deferred revenue	101.2	101.2
Other current liabilities	490.5	427.4
Total current liabilities	2,625.5	2,335.4
Long-term debt	4,056.8	4,055.3
Deferred income tax liabilities, net	424.5	390.8
Long-term pension and other postretirement benefit liabilities	101.8	103.4
Other long-term liabilities	253.3	241.1
Total liabilities	7,461.9	7,126.0
Commitments and Contingencies (see Note 6)
Redeemable noncontrolling interests	121.5	114.4
Equifax shareholders' equity:
Preferred stock, $0.01 par value: Authorized shares - 10.0; Issued shares - none	0.0	0.0
Common stock, $1.25 par value: Authorized shares - 300.0; Issued shares - 189.3 at June 30, 2026 and December 31, 2025; Outstanding shares - 117.6 and 120.4 at June 30, 2026 and December 31, 2025, respectively	236.6	236.6
Paid-in capital	2,082.7	2,023.4
Retained earnings	6,666.3	6,445.1
Accumulated other comprehensive loss	(460.1)	(517.1)
Treasury stock, at cost, 71.1 shares and 68.3 shares at June 30, 2026 and December 31, 2025, respectively	(4,139.4)	(3,577.8)
Stock held by employee benefits trusts, at cost, 0.6 shares at June 30, 2026 and December 31, 2025	(5.9)	(5.9)
Total Equifax shareholders’ equity	4,380.2	4,604.3
Noncontrolling interests	18.2	19.5
Total shareholders' equity	4,398.4	4,623.8
Total liabilities, redeemable noncontrolling interests, and shareholders' equity	11,981.8	11,864.2
Capitalized internal-use software and system costs
Property and equipment:
Total property and equipment	2,885.9	3,098.2
Data processing equipment and furniture
Property and equipment:
Total property and equipment	231.5	239.3
Land, buildings and improvements
Property and equipment:
Total property and equipment	$ 296.7	$ 299.6